Results 41 to 50 of about 33,657 (222)

Dengue vaccines for travelers

Expert Review of Vaccines, 2008
Dengue is an arthropod-borne infection caused by a flavivirus and spread by the Aedes mosquitoes. Many of the countries where dengue is endemic are popular tourist destinations and the disease is an increasingly important problem encountered by international travelers.
Annelies, Wilder-Smith, Jacqueline L, Deen   +1 more
openaire   +2 more sources

Dengue vaccines [PDF]

Microbiology Australia, 2011
Dengue is globally the most important arboviral infection of humans with an estimated 100 million infections per annum and 2.5 billion people at risk in >100 countries. The burden of dengue is substantial in economic terms and in the strain it places on already fragile health systems.
Jamie Whitehorn, Cameron P Simmons
openaire   +1 more source

Acceptability of a hypothetical dengue vaccine and the potential impact of dengue vaccination on personal vector control behavior: a qualitative study in Fortaleza, Brazil

BMC Public Health, 2023
Background Dengue is the most rapidly spreading viral vector-borne disease in the world. Promising new dengue vaccines have contributed to a growing consensus that effective dengue control will require integrated strategies of vaccination and vector ...
Valerie K. Scott, Maria Suelly Nogueira Pinheiro, Marcia Maria Tavares Machado, Marcia C. Castro   +3 more
doaj   +1 more source

Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection. [PDF]

, 2011
BACKGROUND: Dengue virus is transmitted by mosquitoes and has four serotypes. Cross-protection to other serotypes lasting for a few months is observed following infection with one serotype.
Low, Jenny G., Bela-Ong, D.B., Gu, F., Martin L. Hibberd, Fink, Katja, Mickey B Koh, Hibberd, Martin, L, Martin L Hibberd, Katja Fink, Ooi Eng Eong, Leo Yee Sin, Toh, Ying, Xiu, Balakrishnan, Thavamalar, Jenny G Low, Leo, Yee Sin, Balakrishnan, T., Devi, S., Toh Ying Xiu, Dennis B Bela-Ong, Marie Flamand, Flamand, M., Hibberd, Martin L., Flamand, Marie, Leo, Y.S., Flamand Marie, Devi Shamala, Bela-Ong, Dennis, B, Thavamalar Balakrishnan, Yee Sin Leo, Fink Katja, Fink, K., Hibberd, M.L., Jenny G. Low, Ying Xiu Toh, Ooi, E.E., Toh, Y.X., Gu Feng, Ooi, Eng, Eong, Leo, Yee, Sin, Koh, Mickey B., Hibberd Martin L., Bela-ong, Dennis B., Koh, Mickey, B, Eng Eong Ooi, Feng Gu, Low, J.G., Dennis B. Bela-Ong, Balakrishnan Thavamalar, Low, Jenny G, Low Jenny G., Shamala Devi, Toh, Ying Xiu, Bela-Ong, Dennis B, Low, Jenny, G, Mickey B. Koh, Koh Mickey B., Devi, Shamala, Ooi, Eng Eong, Hibberd, Martin L, Koh, M.B., Bela-Ong Dennis B., Koh, Mickey B, Gu, Feng   +62 more
core   +1 more source

Estimates of dengue force of infection in children in Colombo, Sri Lanka. [PDF]

, 2013
Dengue is the most important vector-borne viral disease worldwide and a major cause of childhood fever burden in Sri Lanka, which has experienced a number of large epidemics in the past decade.
Harold S Margolis, Margolis H.S., Aruna Dharshan De Silva (350174), Tam, Clarence C., Amarasinge, Ananda, Margolis, Harold S., de Silva A.D., de Silva, Aravinda M, Clarence C Tam, Harold S. Margolis (147272), Tissera, Hasitha, Aruna Dharshan De Silva, Aravinda M. de Silva (180486), de Silva, Aravinda M., Clarence C. Tam (378980), Hasitha Tissera (419200), Tam, Clarence C, Ananda Amarasinge (419201), Aravinda M de Silva, Tissera H., de Silva A.M., Amarasinge A., De Silva, Aruna Dharshan, Tam C.C., Hasitha Tissera, Ananda Amarasinge, Margolis, Harold S   +26 more
core   +1 more source

Bioethics of establishing a CHIM model for dengue vaccine development

International Journal of Infectious Diseases, 2019
Introduction: Controlled human infection models (CHIM) have been used in vaccine development to up-select and down-select potential vaccine candidates and to provide proof of vaccine efficacy, and have also been used as a basis for licensure of vaccines ...
Anuradha Rose, Amrita Sekhar
doaj   +1 more source

A Dengue Vaccine: Will It be Accepted and Is It Feasible? Lessons from Barranquilla, Colombia, and Merida, Venezuela

Microorganisms, 2019
With one vaccine on the market and others in clinical trials, policy makers in dengue endemic regions face the decision of whether to introduce a dengue vaccine in their communities.
Elizabeth McMahon, Liliana Encinales, Carlos Navarro Encinales, Silvana Vielma, Nelly Pacheco, Lil Geraldine Avendaño Echavez, Sandra Acosta Rodríguez, Milena Calderon, Silvia Encinales Sanabria, Lorena Encinales Sanabria, Ericka Serrano Bernal, Andrés Gonzaléz Coba, Dennys Jiménez, Gary Simon, Aileen Y. Chang   +14 more
doaj   +1 more source

Dengue vaccine development: Global and Indian scenarios

International Journal of Infectious Diseases, 2019
India is home to nearly a third of the global population at risk of dengue, a viral disease caused by four antigenically and genetically distinct dengue viruses.
Sathyamangalam Swaminathan, Navin Khanna
doaj   +1 more source

Vaccines licensed and in clinical trials for the prevention of dengue

Human Vaccines & Immunotherapeutics, 2017
Dengue has become a major global public health threat with almost half of the world's population living in at-risk areas. Vaccination would likely represent an effective strategy for the management of dengue disease in endemic regions, however to date ...
J. Torresi, G. Ebert, M. Pellegrini
doaj   +1 more source

Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity

Frontiers in Immunology, 2020
Dengue is one of the most frequently transmitted mosquito-borne diseases in the world, which creates a significant public health concern globally, especially in tropical and subtropical countries.
Abdullah M. Izmirly, Abdullah M. Izmirly, Abdullah M. Izmirly, Sana O. Alturki, Sana O. Alturki, Sawsan O. Alturki, Sawsan O. Alturki, Jennifer Connors, Jennifer Connors, Elias K. Haddad, Elias K. Haddad   +10 more
doaj   +1 more source